logo

For the Inventor, By the Inventor

Germantown, MD, United States of America

Senseonics, Incorporated


USPTO Granted Patents = 119



Trademarks = 14

Forward Citations = 378

Loading Chart...
Loading Chart...

64 inventors (with patents filed for the assignee):

goldMedal Andrew Dehennis (62 out of 64 patents)

silverMedal Todd Whitehurst (30 out of 39 patents)

bronzeMedal Philip Huffstetler (27 out of 27 patents)

4.  Abhi Chavan (21 out of 21 patents)

5.  Jeremy Emken (19 out of 19 patents)

6.  James Masciotti (18 out of 18 patents)

7.  Xiaoxiao Chen (14 out of 14 patents)

8.  Szymon Tankiewicz (14 out of 14 patents)

9.  Ravi Rastogi (11 out of 11 patents)

10.  Barkha Raisoni (11 out of 11 patents)

11.  Arthur Earl Colvin (10 out of 38 patents)

12.  Barbara Montgomery (9 out of 9 patents)

13.  Venkata Velvadapu (9 out of 9 patents)

14.  Mark Mortellaro (7 out of 12 patents)

15.  Patricia Sanchez (6 out of 6 patents)


Core Competencies:
Analyte Monitoring
Continuous Glucose Monitoring
Calibration Frequency
Wireless Implantable Devices
Signal Degradation
Environmental Detection
Optical Filter Systems
Performance Assessment
Interference Detection
Tactile Feedback
Data Management Systems
Drug Eluting Matrix

119 patents:

1. 12495992 - Mediation of in vivo analyte signal degradation (2025-12-16),
2. 12478330 - Analyte monitoring system and method for determining system usage (2025-11-25),
3. 12478297 - Methods and systems for reducing difference between calculated and measured analyte levels (2025-11-25),
4. 12465213 - Continuous analyte monitoring system (2025-11-11),
5. 12458262 - Dynamic modification of calibration frequency (2025-11-04),
6. 12446795 - Enclosure for a wireless implantable device with embedded power source (2025-10-21),
7. 12419551 - Mediation of in vivo analyte signal degradation (2025-09-23),
8. 12414714 - System and method for continuous and on-demand analyte monitoring (2025-09-16),
9. 12408844 - Implant finder (2025-09-09),
10. 12369824 - Detecting and correcting for interference in an analyte monitoring system (2025-07-29),
11. 12350044 - Analyte monitoring systems and methods that make use of information about a condition of the environment surrounding an analyte sensor (2025-07-08),
12. 12346275 - Remotely-powered sensing system with multiple sensing devices (2025-07-01),
13. 12310693 - Analyte sensor transceiver configured to provide tactile, visual, and/or aural feedback (2025-05-27),
14. 12303265 - Methods and systems for calculating analyte levels (2025-05-20),
15. 12279862 - Mediation of in vivo analyte signal degradation (2025-04-21),
Senseonics is a medical technology company that develops, manufactures, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. Their innovative CGM system, Eversense, offers an extended-wear implantable sensor that can continuously measure glucose levels for up to 90 days, providing patients with accurate and reliable data to manage their diabetes. Senseonics aims to improve the lives of individuals with diabetes by delivering lasting and convenient glucose monitoring solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
119 Patents

#2 in Germantown, MD

#25 in Maryland

#3,117 in US

#6,491 in the World

...
Germantown, MD, United States of America

Senseonics, Incorporated

Forward Citations = 378

64 inventors:

goldMedal Andrew Dehennis (62 out of 64 patents)

silverMedal Todd Whitehurst (30 out of 39 patents)

bronzeMedal Philip Huffstetler (27 out of 27 patents)

4.  Abhi Chavan (21 out of 21 patents)

5.  Jeremy Emken (19 out of 19 patents)

Please report any incorrect information to support@idiyas.com
Loading…